Committed to a
world WITHOUT
Alzheimer’s disease.
Alzheimer’s Therapeutic Research Institute
We are on a path to success in solving the problem of Alzheimer’s Disease (AD). We have a roadmap for our research; build upon amyloid removing treatments, add tau treatments and ultimately prevent the disease altogether.
About UsOur Impact
We lead the way in AD research

We create rigorous trial designs and analytical approaches.

We have a commitment to open science; sharing data to accelerate discoveries.

We create rigorous trial designs and analytical approaches.
Take Action
How YOU Can Make an
Impact
Here at ATRI we rely on our community to make a difference when it comes to advancing AD research. You can help be a part of that, whether through direct participation or supporting the Institute.
Featured researcher
Cecily Jenkins, PhD

Recently Published Works
Safety, Efficacy, and Feasibility of Intranasal insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial JAMA Neurol. 2020 Sep 1;77(9):1099-1109

Recognitions
Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research Alzheimers Res Ther. 2020 Jun 30;12(1):78. doi: 10.1186/s13195-020-00643-0

Panels & Presentations
Identification of Alzheimer disease risk by functional magnetic resonance imaging Arch Neurol. 2005 Dec;62(12):1881-8. doi: 10.1001/archneur.62.12.1881.

Press and Media Mentions
Founding director of USC ATRI

Read the Publications
Paul Aisen, MD
Contribution of Alzheimer’s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer’s disease continuum
Using the Alzheimer’s Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer’s disease
The case for low-level BACE1 inhibition for the prevention of Alzheimer’s disease
Learn MoreHow can YOU Take Action
You can help prevent Alzheimer’s. There are a number of ways to take action.
